SEC Form 4 · accession 0001209191-16-142162
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William F Daniel
Director
Period of report
Sep 19, 2016
Accepted (ET)
Sep 20, 2016 · 4:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Sep 19, 2016 | M | 7,874 | — | A | 17,035 | I | By Trust |
| Ordinary Shares | Sep 19, 2016 | F | 2,381 | $19.12 | D | 14,654 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Sep 19, 2016 | M | 7,874 | D | — | — | Ordinary Shares | 7,874 | 7,874 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- F2The restricted stock units vest in three equal annual installments on each anniversary of the vesting commencement date (September 19, 2014).